ERBB2 and breast cancer: Such patient-derived models have also been demonstrated by others to faithfully maintain histology [57-63], gene expression patterns [60-63] and genomic features [57,58,61,63,64] in diverse human breast cancers, including triple-negative, ER positive and HER2-overexpressing tumors.